Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Thu, 30.01.2025
bonyf NV
bonyf NV
/ Key word(s): Product Launch/Market Launch
bonyf R&D presents its two latest innovations at IDS 2025 in Cologne 30-Jan-2025 / 23:21 CET/CEST
bonyf R&D presents its two latest innovations at IDS 2025 in Cologne
Knokke-Heist (Belgium), 30 January 2025, 6:00 p.m.; bonyf NV (Mnemonic: ML [ … ]
Thu, 30.01.2025
bonyf NV
bonyf NV
/ Key word(s): Product Launch/Market Launch
bonyf R&D presents its two latest innovations at IDS 2025 in Cologne 30-Jan-2025 / 23:21 CET/CEST
bonyf R&D presents its two latest innovations at IDS 2025 in Cologne
Knokke-Heist (Belgium), 30 January 2025, 6:00 p.m.; bonyf NV (Mnemonic: ML [ … ]
Thu, 30.01.2025
Baader Bank AG
New Chairman of the Supervisory Board of Baader Bank elected
With immediate effect, a change at the top of the Supervisory Board was decided today by the Supervisory Board of Baader Bank in an extraordinary Supervisory Board meeting. To ensure an organised succession, Mr. Helmut Schreyer hands over the position of Chairman of the Supervisory Board [ … ]
Thu, 30.01.2025
Baader Bank AG
Supervisory Board elects new Chairman
Baader Bank's Supervisory Board has decided a change at the top of the Board in an extraordinary meeting today.
To ensure an organised succession, Mr. Helmut Schreyer hands over the position of Chairman of the Supervisory Board of Baader Bank at his own request. Accordingly, Dr Louis Hagen is elected as the n [ … ]
Thu, 30.01.2025
Affluent Medical SA
Affluent Medical announces 10th successful human implantation of its Artus urinary sphincter, marking completion of the pilot phase
Completion of the pilot phase of the European multicenter clinical study in humans with the successful 10th minimally invasive implantation of the Artus urinary sphincter.
100% successful activation of implanted dev [ … ]
Thu, 30.01.2025
LIBERO football finance AG
Frankfurt am Main, January 30, 2025 – LIBERO football finance AG announces that the auditor has issued a disclaimer of opinion on the financial statements and management report for the 2023 financial year. The financial statements were approved by the Supervisory Board on January 30, 2025, and are thus finalized. They are expected to be published o [ … ]
Thu, 30.01.2025
Hardman & Co Research
Hardman & Co Research on Apax Global Alpha (APAX):
AGA passed inflexion point with deal activity rising
As noted in our reports, CM day: further proof of value added by Apax and 1H’24: deal activity coming back strongly, the stock of exit-able businesses is rebuilding at a time when market demand is returning. Apax Funds appear to have tu [ … ]
Thu, 30.01.2025
IMMOFINANZ AG
Press Release | Corporate News Vienna, 30 January 2025
IMMOFINANZ becomes CPI Europe
Today’s extraordinary general meeting adopted the renaming of IMMOFINANZ AG to CPI Europe AG on the basis of the amended resolution proposed by the majority shareholder CPI Property Group. With the new name, the company’s affiliation with CPI Property Group [ … ]
Thu, 30.01.2025
Global Uranium Corp.
Global Uranium and Forum Energy Metals Announce Exploration Update on Drill Targeting, Northwest Athabasca Project, Saskatchewan
Reprocessing of historical electromagnetic data has added greater targeting certainty and will help augment a planned winter 2025 drill program on the Northwest Athabasca Project in Saskatchewan’s Athabasca Basin
Januar [ … ]
Thu, 30.01.2025
Rentschler Biopharma SE
Rentschler Biopharma announces strategic realignment of its global business operations
Laupheim (Germany), 30. January 2025 – Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced today a realignment of its global business operations as part of a long-term strategic s [ … ]